Acadia Pharmaceuticals (ACAD) Selling, General & Administrative (2010 - 2026)
Acadia Pharmaceuticals (ACAD) Selling, General & Administrative (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -10.08 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 2.17 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 555.10 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 493.70 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 647.70 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 17.02 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1.13 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 101.25 Mn |
| 10 | Acadia Pharmaceuticals | 4.35 Bn | 3.50 Bn | 243.27 Mn | 171.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 171.02 Mn |
| Dec 31, 2025 | 155.62 Mn |
| Sep 30, 2025 | 133.40 Mn |
| Jun 30, 2025 | 133.51 Mn |
| Mar 31, 2025 | 126.37 Mn |
| Dec 31, 2024 | 130.08 Mn |
| Sep 30, 2024 | 133.29 Mn |
| Jun 30, 2024 | 117.06 Mn |
| Mar 31, 2024 | 107.99 Mn |
| Dec 31, 2023 | 111.47 Mn |
| Sep 30, 2023 | 97.89 Mn |
| Jun 30, 2023 | 95.97 Mn |
| Mar 31, 2023 | 101.24 Mn |
| Dec 31, 2022 | 104.40 Mn |
| Sep 30, 2022 | 78.11 Mn |
| Jun 30, 2022 | 89.90 Mn |
| Mar 31, 2022 | 96.68 Mn |
| Dec 31, 2021 | 105.91 Mn |
| Sep 30, 2021 | 81.67 Mn |
| Jun 30, 2021 | 96.79 Mn |